Old Web
1310P VinMetAtezo: Phase II trial of metronomic oral vinorelbine (MOV) with atezolizumab (ATZ) for recurrent stage IV NSCLC (GFPC*04-18)**
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI